Long-duration spaceflight is known to reshape astronauts' eyes from the inside — swelling the optic disc, flattening the back of the eyeball, blurring near vision. A new analysis adds a visible, external symptom to that list: the lower eyelids themselves rise during time in orbit, a previously undocumented effect researchers are calling "reverse ptosis."
The findings, published in the journal Ophthalmic Plastic and Reconstructive Surgery, come from a team including researchers at Western Sydney University's School of Medicine, the Center for Space Medicine and Extreme Environments in Berlin, and Saarland University Medical Center in Germany. They analyzed 115 NASA photographs of 13 astronauts taken before, during and after missions, measuring the distance from the center of the cornea to the lower eyelid margin — a standard ophthalmic measurement known as MRD2. That distance shrank by an average of 1 millimeter in microgravity, and all 13 astronauts showed some degree of the shift; 62 percent had a change of a millimeter or more, enough to be clinically noticeable and, in some cases, to encroach on the visual field.
Part of a broader syndrome
The eyelid finding fits into a wider, better-established condition called Spaceflight-Associated Neuro-Ocular Syndrome, or SANS, which NASA says produces at least one measurable eye change in the large majority of astronauts on long missions, including optic disc swelling, a shift toward far-sightedness, and folds in the tissue behind the retina. The leading explanation for SANS is a "cephalad fluid shift": without gravity pulling blood and other fluid toward the legs, roughly two liters of fluid redistribute toward the head, and researchers estimate a small fraction of that — on the order of 50 milliliters — pools in the tissue around the eyes, mechanically pushing the lower lid upward. The authors also point to elastic recoil: facial and eyelid tissue that is normally stretched downward by gravity is free to spring back toward its resting position once that pull disappears.
Ophthalmologists have tracked SANS since it was formally identified in the early 2010s, largely through vision complaints and imaging aboard the International Space Station, where crews now routinely undergo tonometry and fundoscope exams. The eyelid measurement adds a low-cost, photograph-based way to track the syndrome's progression without specialized equipment — potentially useful for monitoring crews on future missions where diagnostic imaging is limited.
The study is a retrospective, photograph-based analysis of a small group — 13 astronauts — rather than a controlled clinical trial, and the authors describe their proposed mechanisms as plausible explanations rather than confirmed causes. Photographic quality, lighting and head angle varied across the source images, which the researchers note as a limitation on precision.
With NASA and other agencies planning longer missions to the Moon and eventually Mars, understanding how facial and ocular tissue responds to extended weightlessness has practical stakes: SANS is currently listed among NASA's highest-priority human health risks for deep-space travel. Follow-up work, the researchers say, should track whether the eyelid changes reverse after return to Earth at the same rate as other SANS symptoms, and whether the degree of shift can help predict which crew members are most likely to develop more serious vision problems.
